Advertisement
x
Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Shlomo Raz, MD

  1. Home
  2. /
  3. authors
  4. /
  5. shlomo-raz-md
Advertisement

Articles by Shlomo Raz, MD

Majority of nocturia patients have nocturnal polyuria

ByJa-Hong Kim, MD,Shlomo Raz, MD
November 1st 2009

Drs. Shlomo Raz and Ja-Hong Kim discuss recent advances in the treatment of stress incontinence.

Advertisement

Latest Updated Articles

  • Majority of nocturia patients have nocturnal polyuria
    Majority of nocturia patients have nocturnal polyuria

    Published: November 1st 2009 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

Sean P. Collins, MD, PhD, outlines the impact of rectal spacers for men with prostate cancer

2

Community practice experience shows early efficacy, favorable safety with nadofaragene

3

ORIC-944 shows promise in combination with ARPIs for mCRPC

4

Suzanne Merrill, MD, on integrating ICIs into clinical practice for NMIBC

5

Jason Hafron, MD, recaps prostate cancer data from ESMO 2025

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us